Enrico Franceschi


Ontology type: schema:Person     


Person Info

NAME

Enrico

SURNAME

Franceschi

Publications in SciGraph latest 50 shown

  • 2022-06-28 Machine learning in neuro-oncology: toward novel development fields in JOURNAL OF NEURO-ONCOLOGY
  • 2022-04-09 Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date? in DRUGS
  • 2021-12-01 Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis in ADVANCES IN THERAPY
  • 2021-08-17 Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? in CLINICAL DRUG INVESTIGATION
  • 2021-06-07 IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment in MOLECULAR DIAGNOSIS & THERAPY
  • 2020-08-12 Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study in BMC CANCER
  • 2019-08-14 Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable? in CHILD'S NERVOUS SYSTEM
  • 2018-07-16 The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria in ONCOLOGY AND THERAPY
  • 2018-04-18 Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab? in JOURNAL OF NEURO-ONCOLOGY
  • 2018-03-13 Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients in SCIENTIFIC REPORTS
  • 2017-11-09 Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study in JOURNAL OF NEURO-ONCOLOGY
  • 2017-07-26 Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria in JOURNAL OF NEURO-ONCOLOGY
  • 2017-07-05 Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts in CNS DRUGS
  • 2016-07-26 Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2016-03-04 Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study in JOURNAL OF NEURO-ONCOLOGY
  • 2016-03-03 Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? in JOURNAL OF NEURO-ONCOLOGY
  • 2016-01-11 Nitrosoureas in the Management of Malignant Gliomas in CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
  • 2015-12-11 Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-11-01 Post progression survival in glioblastoma: where are we? in JOURNAL OF NEURO-ONCOLOGY
  • 2011-04-12 Primary Brain Tumors in the Elderly Population in CURRENT TREATMENT OPTIONS IN NEUROLOGY
  • 2010-12-03 Genetic variation in pediatric and adult brain tumors in NATURE REVIEWS NEUROLOGY
  • 2010-11-20 Medulloblastomas in PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
  • 2010-02-18 Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference in BMC CANCER
  • 2009-01-24 Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-10-25 Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20 in VIRCHOWS ARCHIV
  • 2008-04-23 Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2007-03-13 Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) in BRITISH JOURNAL OF CANCER
  • 2007-02-27 Temozolomide as salvage treatment in primary brain lymphomas in BRITISH JOURNAL OF CANCER
  • 2006-10-03 Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) in BRITISH JOURNAL OF CANCER
  • 2006-09-26 Prognostic factors for anaplastic astrocytomas in JOURNAL OF NEURO-ONCOLOGY
  • 2006-04-28 Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors in JOURNAL OF NEURO-ONCOLOGY
  • 2005-07 Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis in JOURNAL OF NEURO-ONCOLOGY
  • 2004-08-10 Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma in BRITISH JOURNAL OF CANCER
  • 2004-01-06 Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.492077.f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417894.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411474.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413104.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419546.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9027.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411475.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8515.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5608.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416290.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412377.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.158820.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417287.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413363.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414090.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414405.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414682.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18887.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415200.2", 
            "type": "Organization"
          }
        ], 
        "familyName": "Franceschi", 
        "givenName": "Enrico", 
        "id": "sg:person.01073030767.87", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-9332-4677"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073030767.87", 
          "https://orcid.org/0000-0001-9332-4677"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_784.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01073030767.87'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01073030767.87'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01073030767.87'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01073030767.87'


     

    This table displays all metadata directly associated to this object as RDF triples.

    65 TRIPLES      11 PREDICATES      35 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01073030767.87 schema:affiliation N5966403ff82b432bbfb244cf79ba711c
    2 grid-institutes:grid.158820.6
    3 grid-institutes:grid.18887.3e
    4 grid-institutes:grid.410569.f
    5 grid-institutes:grid.411474.3
    6 grid-institutes:grid.411475.2
    7 grid-institutes:grid.412377.4
    8 grid-institutes:grid.413104.3
    9 grid-institutes:grid.413363.0
    10 grid-institutes:grid.414090.8
    11 grid-institutes:grid.414405.0
    12 grid-institutes:grid.414682.d
    13 grid-institutes:grid.415200.2
    14 grid-institutes:grid.416290.8
    15 grid-institutes:grid.417287.f
    16 grid-institutes:grid.417894.7
    17 grid-institutes:grid.418936.1
    18 grid-institutes:grid.419546.b
    19 grid-institutes:grid.51462.34
    20 grid-institutes:grid.5608.b
    21 grid-institutes:grid.6292.f
    22 grid-institutes:grid.8515.9
    23 grid-institutes:grid.9027.c
    24 schema:familyName Franceschi
    25 schema:givenName Enrico
    26 schema:identifier N1c48e4c23aed4b0e8f31256b39afcc63
    27 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073030767.87
    28 https://orcid.org/0000-0001-9332-4677
    29 schema:sdDatePublished 2022-12-01T07:13
    30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    31 schema:sdPublisher N7aeb248b099d418ea5f5bb27d0fdf660
    32 sgo:license sg:explorer/license/
    33 sgo:sdDataset persons
    34 rdf:type schema:Person
    35 N1c48e4c23aed4b0e8f31256b39afcc63 schema:name orcid_id
    36 schema:value 0000-0001-9332-4677
    37 rdf:type schema:PropertyValue
    38 N5966403ff82b432bbfb244cf79ba711c schema:affiliation grid-institutes:grid.492077.f
    39 sgo:isCurrent true
    40 rdf:type schema:OrganizationRole
    41 N7aeb248b099d418ea5f5bb27d0fdf660 schema:name Springer Nature - SN SciGraph project
    42 rdf:type schema:Organization
    43 grid-institutes:grid.158820.6 schema:Organization
    44 grid-institutes:grid.18887.3e schema:Organization
    45 grid-institutes:grid.410569.f schema:Organization
    46 grid-institutes:grid.411474.3 schema:Organization
    47 grid-institutes:grid.411475.2 schema:Organization
    48 grid-institutes:grid.412377.4 schema:Organization
    49 grid-institutes:grid.413104.3 schema:Organization
    50 grid-institutes:grid.413363.0 schema:Organization
    51 grid-institutes:grid.414090.8 schema:Organization
    52 grid-institutes:grid.414405.0 schema:Organization
    53 grid-institutes:grid.414682.d schema:Organization
    54 grid-institutes:grid.415200.2 schema:Organization
    55 grid-institutes:grid.416290.8 schema:Organization
    56 grid-institutes:grid.417287.f schema:Organization
    57 grid-institutes:grid.417894.7 schema:Organization
    58 grid-institutes:grid.418936.1 schema:Organization
    59 grid-institutes:grid.419546.b schema:Organization
    60 grid-institutes:grid.492077.f schema:Organization
    61 grid-institutes:grid.51462.34 schema:Organization
    62 grid-institutes:grid.5608.b schema:Organization
    63 grid-institutes:grid.6292.f schema:Organization
    64 grid-institutes:grid.8515.9 schema:Organization
    65 grid-institutes:grid.9027.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...